Prof Sebastien Giebel talks to ecancer at the ALL Assembly 2018 Meeting in Amsterdam about transplant as a method of treating ALL patients.
Prof Giebel discusses some of the issues surrounding these transplants but how it is still a majorly popular course of treatment.
Prof Giebel also considers how to treat T-cell ALL and whether or not technological advances will alter the landscape for treatment in the near future.
He goes on to say that, if a transplant is needed, recent advancements mean a donor can be found for everyone.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.